Medical Innovation Exchange

Acelyrin scores series C that brings total raised in less than a year past $500M

https://www.fiercebiotech.com/biotech/acelyrin-accelerates-affibodys-inflammatory-disease-drug-phase-3-fueled-300m-series-c

Leave a Comment

Your email address will not be published.

Leave the field below empty!